Advertisement

Topics

MiNA enters NASH deal with Boehringer

04:55 EST 9 Nov 2017 | SmartBrief

Boehringer Ingelheim and MiNA Therapeutics signed an approximately $355.1 million deal to develop drugs that combat the forma -More

Original Article: MiNA enters NASH deal with Boehringer

NEXT ARTICLE

More From BioPortfolio on "MiNA enters NASH deal with Boehringer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...